Researchers from the University of Pennsylvania have employed artificial intelligence to identify novel antimicrobial compounds within venom proteins of snakes, spiders, and scorpions. These venom-derived peptides demonstrate potent antibacterial activity against drug-resistant pathogens, addressing the urgent global crisis of antimicrobial resistance. The study, published in Nature Communications, highlights venom compounds as fast-acting, potent, and specific drug candidates, offering a promising avenue in antibiotic innovation.